The Cooper Companies, Inc. (NYSE:COO) and Ocular Sciences, Inc., (Nasdaq:OCLR) announced today that they have signed a definitive agreement for Cooper to acquire Ocular Sciences, Inc. in a merger for stock and cash having a value of approximately $1.2 billion. The transaction is expected to close in the first quarter of Cooper's 2005 fiscal year, which begins on November 1, 2004.
Long-term Fenwick & West client Ocular Sciences, which the firm represented in its 1997 IPO, was advised by a team lead by corporate partner Barry Kramer and included corporate partners Gordon Davidson, David Michaels and Lynda Twomey. The team also included corporate associates Nicole Black, Brian Hicks, Matthew Rossiter and Kris Withrow. The transaction called for expertise from a number of attorneys in the firm's other practice groups, including tax advice provided by partners Barton Bassett and David Forst, antitrust advice provided by partner Mark Ostrau and employee benefits counsel provided by partner Scott Spector and associate Blake Martell.
Inquiries related to this transaction may be directed to corporate partner Barry Kramer at 650.335.7278 or firstname.lastname@example.org.